Real-World Evidence Circles

04/17/2026

Too much clinical evidence is treated as universal—when in reality, context changes everything.
Our latest article explores the external validity gap: why results proven in trials often fall short in real-world care, and what science must do to close that distance between evidence and practice:

What is the external validity gap? Why clinical evidence fails to generalize—and how real-world data and diversity can restore relevance in medicine.

04/16/2026

The NIH is moving research out of academic centers and into everyday primary care.

On paper, this is exactly what healthcare leaders have argued for: evidence drawn from real patients, real settings, real outcomes.

In practice, it creates a quiet problem executives recognize immediately.
Primary care organizations are built for access, throughput, and reimbursement. Research demands something different: pre-defined measurement, audit trails, and consistency across sites. When research is layered onto clinics without changing how data is captured, leaders don’t get insight — they get noise.

The tension isn’t philosophical. It’s operational.

If community clinics are expected to function as research nodes, the question becomes uncomfortable: are your systems generating evidence regulators can trust, or just activity they can’t use?

This question increasingly affects partnerships, federal participation, and long-term valuation — even if it isn’t showing up on the P&L yet.

Learn more in the article:

NIH pushes decentralized research into primary care to capture real-world, verifiable clinical data for federal evidence standards and broader population inclusion.

04/15/2026

Most healthcare executives are being asked to “use their data more.”

The problem is that much of what we call data has quietly lost its credibility.
When information is copied, resold, and recombined without clear provenance, volume increases while trust declines. Analytics still run. Dashboards still update. But decision-makers start to sense that something is off — not enough to halt operations, but enough to slow conviction.

In healthcare, this creates a subtle tension:
The more data we rely on for clinical, operational, and financial decisions, the harder it becomes to prove where that data truly came from — and whether it deserves confidence.
Regulation, legal exposure, and reputational risk are often treated as external pressures. But they may be signals of a deeper structural issue: markets built on information without verifiable integrity eventually undermine their own value.

If trust can’t be audited, it can’t scale.

Read the full piece to understand what comes next: https://hubs.li/Q04c6yH40

Why data capitalism failed—and how provenance, integrity, and transparency can rebuild trust and value in the next generation of data economies.

04/14/2026

𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐝𝐞𝐜𝐢𝐬𝐢𝐨𝐧𝐬 𝐝𝐞𝐦𝐚𝐧𝐝 𝐜𝐞𝐫𝐭𝐚𝐢𝐧𝐭𝐲—𝐧𝐨𝐭 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐬.

As healthcare enters a new era of AI-enabled decision-making, the difference between deterministic evidence and probabilistic data has never been more critical. This article explores how precise, auditable can eliminate AI hallucinations, meet rising regulatory standards, and close the evidence-to-practice gap.

Read the full article to learn why data precision is becoming a non‑negotiable in modern healthcare:https://hubs.li/Q04bWlKQ0

The page you requested unexpectedly failed to load.

04/14/2026

AI is changing how patients choose their surgeons. Outcomes data is becoming the signal.

Surgeons in the MOTIV™ TKA Circle are thinking ahead — collecting standardized data, owning their outcomes, and preparing for a world where AI helps guide patient decisions.

Interested in joining the MOTIV TKA Circle? Send us a message.

04/13/2026

Most healthcare organizations believe their data problem starts after collection. In practice, it starts much earlier. Executives invest heavily in analytics, , and regulatory submissions—only to find that years are spent cleaning, mapping, and reconciling data that was never designed to support longitudinal insight. What’s called “clinical evidence” often turns out to be a series of disconnected snapshots, not a patient journey.

This creates a quiet tension: Teams are asked to move faster and prove outcomes, while relying on systems optimized for documentation, not decision‑grade evidence. The harder question isn’t how to extract data from EHRs more efficiently. It’s whether the data was structured to be usable at the moment it was created. That shift—from retrospective salvage to prospective design—has significant implications for research velocity, clinical alignment, and regulatory confidence.

https://hubs.li/Q04byDbS0

Move beyond messy EHR data. Learn how the Sequential Hierarchy and Circle Datasets provide a structural shift to prospective, longitudinal clinical data.

04/10/2026

In the digital era, one‑time consent is no longer enough. True fairness in data use comes from transparent, repeatable processes that make accountability visible at every step. Discover how procedural justice is reshaping trust, ethics, and scientific integrity in federated data systems:

Why procedural justice replaces static consent—embedding transparency, accountability, and dynamic control into healthcare data governance.

04/09/2026

Translating research into routine care remains one of healthcare’s biggest challenges. Despite rigorous trials, many promising interventions fail once exposed to real-world complexity.

One key reason is where research begins.

Traditional “bench-to-bedside” models assume that insights generated in controlled environments will hold up across diverse patient populations, workflows, and health systems. In practice, this often leads to a costly disconnect between evidence generation and clinical impact.

An alternative approach flips the paradigm: start with clinical hypotheses rooted directly in real-world care. When research questions originate from frontline clinicians—shaped by operational realities, patient diversity, and health equity needs—the resulting evidence is more actionable from day one.

Practice-grounded observational protocols don’t just improve relevance; they increase adoption. Data captured inside real clinical workflows reflects the decisions healthcare leaders and providers actually face, accelerating the path from evidence to outcomes.

If we want to close the long-standing gap between evidence and practice, we may need to rethink not how carefully we test—but where we begin.

➡️ The full article explores how a practice-grounded sequential research model can reshape clinical evidence generation: https://www.rgnmed.com/post/from-theory-to-practice-grounding-clinical-hypotheses-in-real-world-care

Ground clinical hypotheses in real-world care. Learn how the Sequential Hierarchy of Value closes the relevancy gap in biomedical research.

04/08/2026

𝐖𝐡𝐞𝐧 𝐯𝐨𝐥𝐮𝐦𝐞 𝐛𝐞𝐜𝐨𝐦𝐞𝐬 𝐧𝐨𝐢𝐬𝐞, 𝐭𝐫𝐮𝐬𝐭 𝐢𝐬 𝐭𝐡𝐞 𝐟𝐢𝐫𝐬𝐭 𝐜𝐚𝐬𝐮𝐚𝐥𝐭𝐲.

Healthcare’s race to collect more data has outpaced its ability to verify it—undermining AI reliability, clinician confidence, and operational efficiency. The real advantage now isn’t scale, it’s signal: data that can prove its origin, structure, and integrity.

Discover why the future of healthcare analytics depends on verifiable data, not more of it:

Why more data can mean less insight: how noise undermines AI—and how structured, verifiable data restores trust and reliability in healthcare analytics.

04/07/2026

𝐖𝐡𝐲 𝐝𝐨𝐞𝐬 𝐥𝐨𝐰‑𝐯𝐚𝐥𝐮𝐞 𝐜𝐚𝐫𝐞 𝐩𝐞𝐫𝐬𝐢𝐬𝐭—𝐞𝐯𝐞𝐧 𝐚𝐟𝐭𝐞𝐫 𝐭𝐡𝐞 𝐞𝐯𝐢𝐝𝐞𝐧𝐜𝐞 𝐬𝐚𝐲𝐬 𝐢𝐭 𝐬𝐡𝐨𝐮𝐥𝐝𝐧’𝐭?

Healthcare leaders and clinical researchers know the challenge isn’t only adopting new, effective therapies. It’s de‑adopting practices that high‑quality evidence has already shown to offer little or no benefit. Yet many of these interventions remain embedded in routine care for years—sometimes decades—draining resources and offering no meaningful improvement in outcomes.

As experts increasingly point out, the problem isn’t a lack of evidence. It’s the absence of a structural way to connect real‑world data, clinical decision‑making, and accountability in real time. When evidence and practice operate in separate lanes, outdated care persists by default.

Read the full article to explore how an integrated, prospective data architecture can fundamentally change this dynamic—enabling healthcare systems to act on verified evidence as it emerges, rather than waiting 17 years for change.

If you’re involved in clinical leadership, research, or system‑level transformation, this perspective may challenge how you think about evidence‑to‑practice altogether.

To discuss how this approach could apply within your organization, contact us.

Structural mechanisms for clinical de-adoption. Learn how Circle Datasets eliminate low-value care and medical waste through real-time evidence.

04/07/2026

Healthcare is being reshaped by AI, regulation, and rising expectations for transparency—and data sits at the center of that transformation.

At RegenMed, we are building the next foundation for how healthcare data is created, owned, and applied. As the $4T global healthcare ecosystem evolves, real‑world healthcare data is no longer just valuable—it is essential to delivering better outcomes, advancing science, and enabling .

Our focus is on moving beyond fragmented, costly, and increasingly fragile data brokerage models. Through our patented platform, we deliver 𝐥𝐨𝐧𝐠𝐢𝐭𝐮𝐝𝐢𝐧𝐚𝐥, 𝐯𝐞𝐫𝐢𝐟𝐢𝐚𝐛𝐥𝐞 𝐝𝐚𝐭𝐚𝐬𝐞𝐭𝐬 designed from the start for 𝐫𝐞𝐚𝐥 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥, 𝐬𝐜𝐢𝐞𝐧𝐭𝐢𝐟𝐢𝐜, 𝐚𝐧𝐝 𝐜𝐚𝐫𝐞 𝐝𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐮𝐬𝐞. This approach reflects a broader shift in policy and practice toward clear data ownership, transparency, and actionability.

Moreover, our platform inherently supports expansion. We are advancing Federated Healthcare Data models and new healthcare value frameworks—𝐂𝐢𝐫𝐜𝐥𝐞 𝐇𝐞𝐚𝐥𝐭𝐡 𝐂𝐨𝐢𝐧𝐬—that support collaboration, trust, and scalability across the ecosystem—unlocking new ways to generate and apply evidence at scale.

𝐈𝐦𝐩𝐚𝐜𝐭 𝐫𝐞𝐦𝐚𝐢𝐧𝐬 𝐭𝐡𝐞 𝐠𝐮𝐢𝐝𝐢𝐧𝐠 𝐩𝐫𝐢𝐧𝐜𝐢𝐩𝐥𝐞. Today, it can take an average of 17 years for proven medical evidence to become part of everyday clinical practice. We believe that gap can—and must—be shortened. By rethinking how healthcare data is structured at its foundation, we aim to help insight move faster from discovery to care.

We are guided by first principles and a long‑term view. Our direction is clear: build data systems that accelerate knowledge, improve decision‑making, and ultimately make 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 work 𝐛𝐞𝐭𝐭𝐞𝐫 𝐟𝐨𝐫 𝐞𝐯𝐞𝐫𝐲𝐨𝐧𝐞.

Stay tuned for exciting developments in 2026.

04/06/2026

Healthcare policy is changing — and so is the definition of success.

As federal agencies shift focus from managing chronic disease to reversing it, traditional measures of performance are no longer enough. Billing codes and claims data can show activity, but they can’t prove outcomes.

This emerging gap between care delivered and outcomes verified has real implications for reimbursement, enterprise value, and long-term strategy.

The article explores why outcome data is becoming the new currency in healthcare — and what leaders need to understand now:

Federal health reform prioritizes root-cause chronic disease reversal and demands verified clinical evidence over billing proxies for value-based reimbursement.